Johnson & Johnson MedTech (NYSE: JNJ) announced that it received CE mark approval for its dual-energy ThermoCool SmartTouch ...

Vensana Capital recently announced that it has closed a $425 million Fund III for continued investment in innovative medtech ...

Relief Cardiovascular has closed a $12 million Series A round to help initiate a first-in-human feasibility study for its ...

Saluda Medical announced that it closed a $100 million financing to support its novel closed-loop, dose-control ...

CapsoVision announced today that the FDA cleared its CapsoCam Plus system for use in pediatric patients aged two and above.

Pulse Biosciences (Nasdaq:PLSE) announced today that it appointed Paul A. LaViolette, co-chair of its board, as its new CEO.

BD today announced it appointed Pamela Spikner as senior VP, chief accounting officer, and controller, effective January 20.